Latest Remuneration News

Rincon Resources confirms historic high-grade gold-copper mineralisation extensions at Telfer South and secures a significant joint venture deal for West Arunta, underpinning its exploration focus and capital position.

Cosmos Exploration has completed its merger with EAU Lithium, securing key partnerships and technology to progress lithium development in Bolivia. The company also committed to acquiring a German-built pilot plant to support its VULSORB® extraction technology.

Azzuro Resources has locked in a major copper-gold discovery at its newly acquired Red Hill project in Mongolia, confirming a high-grade VMS system over nearly 550 metres of strike with significant expansion potential.

Capricorn Metals delivered a record 123,589 ounces of gold in FY26 at its Karlawinda Gold Project, with FY27 guidance boosted by the imminent commissioning of its expansion project. Exploration at Mt Gibson and Golden Range continues to yield high-grade results, underpinning future growth.

Talonx Resources (ASX: TXR) reported robust drilling results at its Viking and Blair North gold projects, highlighting a high-grade shallow oxide gold zone at Viking’s Beaker 2 prospect. The company also advanced exploration and licence renewal efforts at its Kihabe zinc-lead-silver project in Botswana, closing the quarter with $0.72 million cash.

Island Pharmaceuticals has marked a major step forward in its antiviral program with the start of GMP manufacturing for Galidesivir, expanded USAMRIID collaboration, and FDA orphan drug designation. Regulatory approvals for compassionate use in Uganda’s Ebola outbreak and a new dose optimisation study with Texas Biomed further de-risk the pathway to approval.

Anson Resources has dramatically expanded its Green River Lithium Project resource and confirmed robust project economics, while sealing a key agreement with POSCO for a demonstration plant funded by the Korean industrial giant.

Emu NL has launched its largest drilling program yet at the Georgetown Copper Project, backed by a recent A$2.98 million capital raise. The company aims to systematically test high-priority copper targets at Yataga Valley following improved geological modeling.

Peak Processing (ASX: PKP) has recorded its first positive Group EBITDA quarter, driven by record beverage production and a significant US manufacturing agreement, marking a pivotal turnaround in FY26.

PYC Therapeutics has made significant progress across its four RNA therapeutic programs, including dose escalation approvals in its Polycystic Kidney Disease trial and orphan drug designation for its Retinitis Pigmentosa candidate, supported by a robust cash position of $669 million.

Sunstone Metals reported strong exploration progress in the June 2026 quarter at its Bramaderos and El Palmar gold-copper projects in Ecuador, highlighted by consistent long mineralised intersections and a $10 million capital raise.

Amplia Therapeutics reported encouraging mature data from its ACCENT trial, initiated a Phase 2b pancreatic cancer study, launched an ovarian cancer trial, and refreshed its board leadership while maintaining a solid cash balance of A$24 million.